Author： Adis International Limited
Publisher： Adis International
ISSN： 1176-3469
Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.9, 2005-01, pp. : 8-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Pulmonary fibrosis in l-NAME-treated mice is dependent on an activated endothelin system
By Mach Alexander Thone-Reineke Christa Godes Michael Heiden Susi Sharkovska Yuliya von Websky Karoline Relle Katharina Hocher Berthold Kalk Philipp
Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 8, 2008-08 ,pp. :
The endothelin receptor antagonist bosentan [`Tracleer'; Actelion] has been approved in Canada
Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. :